蛋白激酶D2介导的维护复合物组件2酸化促进了膀癌的进展
He Tian1, Jing Song1, Junzi Cong2
1Department of Urinary Surgery, Hongqi Hospital Affiliated to Mudanjiang Medical University, No. 5 Tongxiang Road, Aimin District, Mudanjiang, 157011, Heilongjiang, China.
Journal of translational medicine
|November 27, 2025
概括
蛋白激酶D2 (PRKD2) 在膀癌中高度表达,促进瘤生长和转移. 抑制PRKD2会阻碍癌细胞的进展,这表明PRKD2是治疗膀癌的潜在治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 膀癌是一种普遍存在的恶性瘤,由异常的信号通路驱动.
- 蛋白激酶D2 (PRKD2) 在各种人类癌症中发挥着重要作用.
研究的目的:
- 研究PRKD2在膀癌中的作用和机制.
- 确定PRKD2是否是膀癌的潜在治疗点.
主要方法:
- 定量实时PCR,西式涂抹和组织微阵列分析了PRKD2的表达.
- 在体外和体外功能测试中评估了PRKD2.2的影响.
- 定位突变和免疫沉确定了PRKD2的酸化标.
主要成果:
- 在膀癌组织中,PRKD2的表达显著升高.
- 较高的PRKD2水平与转移,高级TNM阶段和不良预后相关.
- PRKD2的枯竭抑制了膀癌细胞的增殖,迁移,入侵和上皮-介质酶过渡.
- 在139级血清中,PRKD2可化MCM2,推动癌症的进展.
结论:
- 通过MCM2酸化,PRKD2有助于膀癌恶性瘤.
- PRKD2代表了膀癌的潜在治疗标.
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
MAPK Signaling Cascades
7.8K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
DNA Damage can Stall the Cell Cycle
9.9K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle
3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K


